Doctor profile · Federal record
Dr. Kelly Ledermann, N.P.
Nurse Practitioner · Garden City, NY
- NPI 1942362215
- Accepts Medicare
- MIPS 75.0 / 100 · 2023
- 21 yrs in practice
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
54 New Hyde Park RD
Garden City, NY 115303909
(516) 488-1313
fax (516) 488-3449
Credentials & registration
- NPI registered
- December 2006 — 20 yrs on file
- Profile last updated
- January 25, 2024
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 363L00000X — NUCC code
- State license (1)
- New York #334555
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1942362215. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
2,537
Distinct HCPCS
10
Medicare allowed
$144,532
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
17003 |
Destruction of precancer skin growth, 2-14 growths | 756 | 151 | $7 | |
99213 |
Established patient office or other outpatient visit, 20-29 minutes | 540 | 448 | $89 | |
99212 |
Established patient office or other outpatient visit, 10-19 minutes | 272 | 205 | $56 | |
17000 |
Destruction of precancer skin growth, 1 growth | 244 | 200 | $50 | |
17110 |
Destruction of skin growth, 1-14 growths | 216 | 182 | $114 | |
11102 |
Biopsy of related skin growth, first growth | 192 | 167 | $89 | |
11103 |
Biopsy of related skin growth, each additional growth | 70 | 40 | $51 | |
J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 66 | 36 | $1 | |
11900 |
Injection into skin growth, 1-7 growths | 51 | 34 | $47 | |
99203 |
New patient office or other outpatient visit, 30-44 minutes | 40 | 40 | $113 |
In context: peer comparison
Among 1 peers in this city , average services per provider: 181. This provider delivers 14× the peer median.Open Payments
Industry payments received
All-time total
$2,579
Transactions
100
Manufacturers
15
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| Arcutis Biotherapeutics, Inc. | 10 | $532.60 | |
| ABBVIE INC. | 20 | $381.20 | |
| Janssen Biotech, Inc. | 5 | $257.29 | |
| E.R. Squibb & Sons, L.L.C. | 10 | $224.04 | |
| Lilly USA, LLC | 7 | $202.99 | |
| PFIZER INC. | 10 | $171.64 | |
| Dermavant Sciences, Inc. | 15 | $154.97 | |
| GENZYME CORPORATION | 4 | $101.48 | |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 5 | $88.98 | |
| SANOFI-AVENTIS U.S. LLC | 1 | $85.00 | |
| UCB, Inc. | 4 | $77.71 | |
| Incyte Corporation | 3 | $67.50 | |
| Regeneron Healthcare Solutions, Inc. | 2 | $60.46 | |
| Galderma Laboratories, L.P. | 2 | $46.86 | |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $42.45 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
770
Patients
515
Total drug cost
$33,967
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Ketoconazole | Generic | 136 | 82 | $3,340 |
| Mupirocin | Generic | 92 | 75 | $800 |
| Triamcinolone Acetonide | Generic | 67 | 52 | $1,426 |
| Ciclopirox (Ciclopirox Olamine) | Brand | 61 | 37 | $2,330 |
| Clobetasol Propionate | Generic | 56 | 37 | $4,098 |
| Fluocinonide | Generic | 56 | 50 | $3,984 |
| Doxycycline Hyclate | Generic | 50 | 27 | $2,242 |
| Halobetasol Propionate | Generic | 47 | 33 | $3,950 |
| Metronidazole | Generic | 44 | 23 | $2,950 |
| Fluorouracil | Generic | 41 | 37 | $3,343 |
Frequently asked questions
What is Dr. Kelly Ledermann's medical specialty?
Dr. Kelly Ledermann practices Nurse Practitioner in Garden City, NY.
Where does Dr. Kelly Ledermann practice?
Dr. Kelly Ledermann practices at 54 New Hyde Park RD, Garden City, NY 115303909. Office phone: 5164881313.
What is Dr. Kelly Ledermann's NPI?
Dr. Kelly Ledermann's National Provider Identifier (NPI) is 1942362215, issued by NPPES.
Does Dr. Kelly Ledermann accept Medicare assignment?
Yes. Dr. Kelly Ledermann accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Kelly Ledermann commonly perform?
Top Medicare-reported procedures in 2023: Destruction of precancer skin growth, 2-14 growths (HCPCS 17003); Established patient office or other outpatient visit (HCPCS 99213); Established patient office or other outpatient visit (HCPCS 99212). Source: CMS Medicare Physician & Other Practitioners file.